IGM Biosciences, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.19 | $291.95 M | -3.13 | 54 | $0 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CGEM
Cullinan Oncology, Inc. |
$12.27 | $1.29 B | -7.16 | 85 | $0 |
DSGN
Design Therapeutics, Inc. |
$6.35 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.57 | $647.94 M | -2.83 | 126 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.05 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.54 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
Ikena Oncology, Inc. |
$1.53 | $84.45 M | -1.11 | 14 | $9.16 M |
MLYS
Mineralys Therapeutics, Inc. |
$12.80 | $652.38 M | -6.03 | 28 | $0 |
PASG
Passage Bio, Inc. |
$0.65 | $73.04 M | -0.77 | 58 | $0 |
RNA
Avidity Biosciences, Inc. |
$31.35 | $2.54 B | -8.99 | 253 | $9.56 M |
RVMD
Revolution Medicines, Inc. |
$44.39 | $6.66 B | -10.51 | 490 | $11.58 M |
STOK
Stoke Therapeutics, Inc. |
$11.32 | $774.50 M | -6.14 | 110 | $8.78 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |